Patents by Inventor Paul W. Baures

Paul W. Baures has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
    Publication number: 20120178754
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: March 22, 2012
    Publication date: July 12, 2012
    Applicant: Compass Pharmaceuticals LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Herman J. Verheij, Jan C.C. Schultz
  • Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
    Publication number: 20100222356
    Abstract: The present invention provides novel compounds and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: May 10, 2010
    Publication date: September 2, 2010
    Applicant: Compass Pharmaceuticals LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Herman J. Verheij, Jan C.C. Schultz
  • Furazano '3, 4-B! Pyrazines and Their Use as Anti-Tumor Agents
    Publication number: 20090131445
    Abstract: The present invention provides novel compounds of the formula (I) and pharmaceutical compositions thereof, as well as methods for using the compounds and pharmaceutical compositions for treating tumors. Examples of specific tumor types that the compounds may be used to treat include, but are not limited to sarcomas, melanomas, neuroblastomas, carcinomas (including but not limited to lung, renal cell, ovarian, liver, bladder, and pancreatic carcinomas), and mesotheliomas.
    Type: Application
    Filed: October 12, 2005
    Publication date: May 21, 2009
    Applicant: COMPASS PHARMACEUTICALS LLC
    Inventors: Paul W. Baures, Donald R. James, Richard D. Gless, Thuy Tran, Jan C.C. Schultz
  • Compositions and methods for the treatment of hepatitis C virus infection
    Patent number: 7208628
    Abstract: This invention relates to methods and compositions directed towards the diagnosis and treatment of Hepatitis C virus infection and the screening of potential therapeutic compounds using novel small molecules based on imidazole-4,5-dicarboxylic acids scaffolds.
    Type: Grant
    Filed: May 13, 2002
    Date of Patent: April 24, 2007
    Assignee: Kansas State University Research Foundation
    Inventors: Scott C. Todd, Paul W. Baures
  • Compositions and methods for the treatment of hepatitis C virus infection
    Publication number: 20030219893
    Abstract: This invention relates to methods and compositions directed towards the diagnosis and treatment of Hepatitis C virus infection and the screening of potential therapeutic compounds using novel small molecules based on imidazole-4,5-dicarboxylic acids scaffolds.
    Type: Application
    Filed: May 13, 2002
    Publication date: November 27, 2003
    Applicant: Kansas State University Research Foundation
    Inventors: Scott C. Todd, Paul W. Baures
  • Aspartic protease inhibitors
    Patent number: 6184241
    Abstract: The present invention is directed to aspartic protease inhibitors, in particular to HIV protease, renin, pepsin and cathepsin D inhibitors. Inhibitors of the present invention have a 3 to 12-membered heterocyclic core containing at least two heteroatoms which interact with the carboxyl groups of the aspartic acid residues in the active site of the protease to inhibit the action thereof.
    Type: Grant
    Filed: August 24, 1998
    Date of Patent: February 6, 2001
    Assignee: Kansas State University Research Foundation
    Inventor: Paul W. Baures